ID

35264

Descrizione

Study ID: 100449 Clinical Study ID: 100449 Study Title: Long-term Follow-Up studies at Years 16-20, to evaluate the persistence of immune response of GSK Biologicals’ hepatitis B vaccine in newborns of HBeAg+ and HBsAg+ mothers in comparison with a historical control group Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00240539 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis B Vaccine, Recombinant Trade Name: Engerix-B Study Indication: Hepatitis B

Keywords

  1. 25/02/19 25/02/19 -
Titolare del copyright

GSK group of companies

Caricato su

25 febbraio 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Persistence of immune response of Hepatitis B vaccine in newborns of HBeAg+ and HBsAg+ mothers

Visit 22 - 26 (Follow-Up)

Visit 22 (Year 16) Follow-up
Descrizione

Visit 22 (Year 16) Follow-up

Protocol
Descrizione

Protocol

Tipo di dati

integer

Center
Descrizione

Center

Tipo di dati

integer

Date of visit
Descrizione

Date of visit

Tipo di dati

date

Subject Number
Descrizione

Subject Number

Tipo di dati

integer

INFORMED CONSENT
Descrizione

INFORMED CONSENT

I certify that Informed Consent has been obtained prior to any study procedure.
Descrizione

I certify that Informed Consent has been obtained prior to any study procedure.

Tipo di dati

boolean

Informed Consent Date
Descrizione

InformedConsentDate

Tipo di dati

date

DEMOGRAPHICS
Descrizione

DEMOGRAPHICS

Date of birth:
Descrizione

PREVIOUS STUDY: 103860/272 (EXT: HBV-115) Subject number will be the same as in the previous study.

Tipo di dati

date

Gender
Descrizione

Gender

Tipo di dati

text

Race
Descrizione

Race

Tipo di dati

text

If Other, please specify race
Descrizione

OtherRace

Tipo di dati

text

Height
Descrizione

Height

Tipo di dati

integer

Unità di misura
  • cm
cm
Weight
Descrizione

Weight

Tipo di dati

float

Unità di misura
  • kg
kg
LABORATORY TESTS
Descrizione

LABORATORY TESTS

Has a blood sample been taken?
Descrizione

BLOOD SAMPLE

Tipo di dati

boolean

If Yes, please record the date
Descrizione

DateBloodSampleTaken

Tipo di dati

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Descrizione

PreviousHepatitisVaccination

Tipo di dati

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Descrizione

PreviousHistoryOfHipatitisB

Tipo di dati

boolean

If Yes, please specify below
Descrizione

Specify

Tipo di dati

text

Visit 23 (Year 17) Follow-up
Descrizione

Visit 23 (Year 17) Follow-up

Date of visit
Descrizione

VisitDate

Tipo di dati

date

LABORATORY TESTS
Descrizione

LABORATORY TESTS

Has a blood sample been taken?
Descrizione

BLOOD SAMPLE

Tipo di dati

boolean

Please specify the date of blood sample taken
Descrizione

DateBloodSampleTaken

Tipo di dati

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Descrizione

PreviousHepatitisBVaccination

Tipo di dati

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Descrizione

PreviousHistoryOfHepatitisB

Tipo di dati

boolean

If Yes, please specify
Descrizione

Specify

Tipo di dati

text

Visit 24 (Year 18) Follow-up
Descrizione

Visit 24 (Year 18) Follow-up

Date of visit
Descrizione

Visit Date

Tipo di dati

date

LABORATORY TESTS
Descrizione

LABORATORY TESTS

Has a blood sample been taken?
Descrizione

BLOOD SAMPLE

Tipo di dati

boolean

Please specify the date of blood sample taken
Descrizione

DateBloodSampleTaken

Tipo di dati

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Descrizione

PreviousHepatitisBVaccination

Tipo di dati

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Descrizione

PreviousHistoryOfHepatitisB

Tipo di dati

boolean

If Yes, please specify
Descrizione

Specify

Tipo di dati

text

Visit 25 (Year 19) Follow-up
Descrizione

Visit 25 (Year 19) Follow-up

Date of visit
Descrizione

VisitDate

Tipo di dati

date

LABORATORY TESTS
Descrizione

LABORATORY TESTS

Has a blood sample been taken?
Descrizione

BLOOD SAMPLE

Tipo di dati

boolean

Please specify the date of blood sample taken
Descrizione

DateBloodSampleTaken

Tipo di dati

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Descrizione

PreviousHepatitisBVaccination

Tipo di dati

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Descrizione

PreviousHistoryOfHepatitisB

Tipo di dati

boolean

If Yes, please specify
Descrizione

Specify

Tipo di dati

text

Visit 26 (Year 20) Follow-up
Descrizione

Visit 26 (Year 20) Follow-up

Date of visit
Descrizione

VisitDate

Tipo di dati

date

LABORATORY TESTS
Descrizione

LABORATORY TESTS

Has a blood sample been taken?
Descrizione

BLOOD SAMPLE

Tipo di dati

boolean

Please specify the date of blood sample taken
Descrizione

DateBloodSampleTaken

Tipo di dati

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Descrizione

PreviousHepatitisBVaccination

Tipo di dati

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Descrizione

PreviousHistoryOfHepatitisB

Tipo di dati

boolean

If Yes, please specify
Descrizione

Specify

Tipo di dati

text

FOLLOW-UP STUDIES
Descrizione

FOLLOW-UP STUDIES

Would the subject be willing to participate in a follow-up study?
Descrizione

FollowUpStudiesParticipation

Tipo di dati

boolean

If No, please specify
Descrizione

If No, please specify

Tipo di dati

text

If AE or SAE, please specify
Descrizione

AE/SAE

Tipo di dati

text

If Other, please specify
Descrizione

OtherSpecify

Tipo di dati

text

INVESTIGATOR'S SIGNATURE
Descrizione

INVESTIGATOR'S SIGNATURE

I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
Descrizione

Investigator'sConfirmationDate

Tipo di dati

date

Investigator's signature
Descrizione

Investigator's signature

Tipo di dati

text

Printed Investigator's name
Descrizione

Printed Investigator's name

Tipo di dati

text

Reason for non participation
Descrizione

Reason for non participation

Protocol number
Descrizione

Protocol number

Tipo di dati

integer

Center
Descrizione

Center

Tipo di dati

integer

Previous study
Descrizione

e.g., 103860 / 272 (EXT:HBV-115)

Tipo di dati

text

Tracking Document
Descrizione

Tracking Document

Previous Subject Number
Descrizione

Previous Subject Number

Tipo di dati

integer

Date of Birth
Descrizione

BirthDate

Tipo di dati

date

Please document reason for non participation
Descrizione

Please document reason for non participation

Tipo di dati

text

In case of death, please specify date
Descrizione

DeathDate

Tipo di dati

date

Date of Contact
Descrizione

Date of Contact

Tipo di dati

date

Investigator's Signature
Descrizione

Investigator's Signature

Investigator name
Descrizione

please PRINT name

Tipo di dati

text

Signature:
Descrizione

Signature:

Tipo di dati

text

Date:
Descrizione

Date:

Tipo di dati

date

Similar models

Visit 22 - 26 (Follow-Up)

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Visit 22 (Year 16) Follow-up
Protocol
Item
Protocol
integer
Center
Item
Center
integer
Date of visit
Item
Date of visit
date
Subject Number
Item
Subject Number
integer
Item Group
INFORMED CONSENT
I certify that Informed Consent has been obtained prior to any study procedure.
Item
I certify that Informed Consent has been obtained prior to any study procedure.
boolean
InformedConsentDate
Item
Informed Consent Date
date
Item Group
DEMOGRAPHICS
Date of birth:
Item
Date of birth:
date
Item
Gender
text
Code List
Gender
CL Item
Male (1)
CL Item
Female (2)
Item
Race
text
Code List
Race
CL Item
Black (1)
CL Item
Arabic/North African (2)
CL Item
White/Caucasian (3)
CL Item
East & South East Asian (4)
CL Item
South Asian (5)
OtherRace
Item
If Other, please specify race
text
Height
Item
Height
integer
Weight
Item
Weight
float
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
If Yes, please record the date
date
PreviousHepatitisVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHipatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify below
text
Item Group
Visit 23 (Year 17) Follow-up
VisitDate
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
Visit 24 (Year 18) Follow-up
Visit Date
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
Visit 25 (Year 19) Follow-up
VisitDate
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
Visit 26 (Year 20) Follow-up
VisitDate
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
FOLLOW-UP STUDIES
FollowUpStudiesParticipation
Item
Would the subject be willing to participate in a follow-up study?
boolean
Item
If No, please specify
text
Code List
If No, please specify
CL Item
Adverse Events, or Serious Adverse Events (1)
CL Item
Other (2)
AE/SAE
Item
If AE or SAE, please specify
text
OtherSpecify
Item
If Other, please specify
text
Item Group
INVESTIGATOR'S SIGNATURE
Investigator'sConfirmationDate
Item
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
date
Investigator's signature
Item
Investigator's signature
text
Printed Investigator's name
Item
Printed Investigator's name
text
Item Group
Reason for non participation
Protocol number
Item
Protocol number
integer
Center
Item
Center
integer
Previous study
Item
Previous study
text
Item Group
Tracking Document
Previous Subject Number
Item
Previous Subject Number
integer
BirthDate
Item
Date of Birth
date
Item
Please document reason for non participation
text
Code List
Please document reason for non participation
CL Item
Subject not eligible (1)
CL Item
Subject lost to follow-up or not reached (2)
CL Item
Subject eligible but not willing to participate due to adverse events, or serious adverse event (3)
CL Item
Subject eligible but not willing to participate due to other reasons (4)
CL Item
Subject died (5)
DeathDate
Item
In case of death, please specify date
date
Date of Contact
Item
Date of Contact
date
Item Group
Investigator's Signature
Investigator name
Item
Investigator name
text
Signature:
Item
Signature:
text
Date:
Item
Date:
date

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial